New way to test antibiotics could lead to better drugs – Phys.Org
Phys.Org |
New way to test antibiotics could lead to better drugs
Phys.Org For the new study, Collins wanted to apply synthetic biology—the construction of novel genetic circuits in living cells—to design bacteria that could be used to study antibiotics and infection. Most studies of how antibiotics work are done with … |
Xconomy |
Bio Roundup: CAR–T’s Huge Week, Merck’s ‘Pib Choice & More
Xconomy The far-out idea of reprogramming a patient’s immune cells to fight cancer, known as CAR–T, entered the mainstream this week, and two numbers highlight the tale. The first is $11.9 billion, the price Gilead Sciences is paying for Kite Pharma and its … Gilead’s Acquisition Of Kite Pharma Relieves Shareholders’ EnnuiSeeking Alpha |
New Scientist |
Pioneering gene therapy approved for leukaemia in the US
New Scientist A CAR-T treatment – a type of gene therapy for cancer – has been approved for use in the US. Announced by the US Food and Drug Administration (FDA) on Wednesday, this is the first approval anywhere in the world for a type of CAR-T therapy, although the … US clears breakthrough gene therapy for childhood leukemiaABC News First Gene Therapy Treatment Approved in USSmithsonian FDA approves a ‘historic’ new type of leukemia treatmentToday.com FDA.gov –National Cancer Institute –National Cancer Institute –NPR all 578 news articles » |
|
Barclays Begins Coverage on Editas Medicine, Inc. (EDIT) With A Rating Of “Overweight”
Modern Readers CRISPR uses a protein-ribonucleic acid (RNA) complex composed of an enzyme, including either Cas9 (CRISPR associated protein 9) or Cpf1 (CRISPR from Prevotella and Francisella 1), bound to a guide RNA molecule designed to recognize a particular … |